The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

The Union Health Ministry has launched the e-Blood Bank Portal, making it easier for patients and organisers to access blood ...

Siemens Healthineers announced today its Innovance Antithrombin assay has achieved FDA clearance for a new claim allowing it to be used as a companion diagnostic test for people receiving treatment ...

Lentiviral vector (LV)–based gene therapy using CD34+ hematopoietic stem cells (HSCs) demonstrated stable factor VIII expression in severe hemophilia ... with peripheral-blood vector copy ...

can damage the bone marrow's ability to produce blood cells, making transfusions essential for recovery. Patients with clotting disorders, such as haemophilia, may also require transfusions of ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, ...

a cancer of the plasma cells. Another inherited blood disorder is haemophilia, which causes blood to not clot properly. The disorder mostly affects males; Queen Victoria’s male descendants ...

Blood banks regularly update information on this platform, making it easier for patients suffering from thalassemia, haemophilia, sickle cell disease, and other blood-related disorders to find blood ...

Dr. Raches Ella, Chief Development Officer, Bharat Biotech, spearheading this CGT initiative, said that oncology and rare ...

Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration's (FDA) approval of Qfitliatm (fitusiran), the sixth ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, ...

Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...